Vaccination against Helicobacter pylori

Journal of Gastroenterology

Volumn 31, Issue SUPPL. 9, 1996, Pages 69-74

  Lee, Adrian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Gastric cancer; Helicobacter pylori; Immunization; Peptic ulcer

Indexed keywords

ADJUVANT; BACTERIAL ANTIGEN; BACTERIAL VACCINE; ESCHERICHIA COLI ENDOTOXIN; UREASE;

CONFERENCE PAPER; GRAM NEGATIVE INFECTION; HELICOBACTER; HELICOBACTER PYLORI; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNIZATION; JAPAN; MICE;

EID: 0030471895     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01211189     Document Type: Conference Paper

References (50)

1. Marshall BJ. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983;I:1273-1275.
2. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;I:1273.
3. Kikuchi S, Wada O, Nakajima T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995;75:2789-2793.
4. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans In: Lyon: World Health Organization, 1994;177-240.
5. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-777.
6. Deboer W, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-820.
7. Noach LA, Langenberg WL, Bertola MA, et al. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994;26:321-327.
8. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23s rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477-480.
9. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993;28(Suppl 196):34-37.
10. Lee A, Fox J, Hazell S. Pathogenicity of Helicobacter pylori - a perspective. Infect Immun 1993;61:1601-1610.
11. Vandewouw B, Deboer WA, Jansz AR, et al. Serodiagnosis of Helicobacter pylori infection - an evaluation of a commercially available ELISA-IgG. Neth J Med 1995;47:272-277.
12. Feldman RA, Decks JJ, Evans S. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995;14:428-433.
13. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylon leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
14. Czinn SJ, Nednid JG. Oral immunization against Helicobacter pylori. Infect Immun 1991;59:2359-2363.
15. Nedrud JG, Liang XP, Hague N, et al. Oral/nasal immunisation protects mice from Sendai virus infection. J Immunol 1987;139: 3484-3492.
16. Lycke N, Holmgren J. Stong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunol 1986;59:301-308.
17. Krakowka S, Morgan DR, Kraft WG, et al. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 1987;55:2789-2796.
18. Lee A, Fox JG, Otto G, et al. A small animal model of human Helicobacter pylon active chronic gastritis. Gastroenterol 1990;99. 1315-1323.
19. Paster BJ, Lee A, Fox JG, et al. Phylogeny of Helicobacter felis sp. nov., Helicobacter mustelae, and related bacteria. Int J Syst Bacteriol 1991;41:31-38.
20. Wegmann W, Aschwanden M, Schaub N, et al. Gastritis associated with Gastrospirillum hominis - a zoonosis? Schweiz Med Wochenschr 1991;121:245-254.
21. Dick-Hegedus E, Lee A. Use of a mouse model to examine anti-Helicobacter pylori agents. Scand J Gastroenterol 1991;26.909-915.
22. Enno A, O'Rourke JL, Howlett CR, et al MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis - a mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol 1995;147:217-222.
23. Chen M, Lee A, Hazell SL. Immunisation against Helicobacter infection in a mouse/Helicobacter felis model. Lancet 1992;339: 1120-1121.
24. Chen MH, Lee A, Hazell S, et al. Immunisation against gastric infection with Helicobacter species - first step in the prophylaxis of gastric cancer? Zbl Bakt (Int J Med Microbiol) 1993;280:155-165.
25. Czinn S, Gai A, Nedrud J. Oral immunisation protects germ-free mice against infection from Helicobacter felis. Gastroenterology 1992;102:A331.
26. Czinn SJ, Gai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993;11:637-642.
27. Thomas WD, Lee CK, Lofsky A, et al. Effect of oral imunization with Helicobacter pylori antigens on colonisation by H. felis in mice. Acta Gastro-Enterol Belg 1993;56(S):54.
28. Corthesy-Theulaz I, Haas R, Davin C, et al. Helicobacter pylori urease elicits protection against Helicobacter felis infection in mice. Acta Gastro-Enterol Belg 1993;56(S):64.
29. Eaton KA, Brooks CL, Morgan DR, et al. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991;59:2470-2475.
30. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991;173:1920-1931.
31. Mobley H, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995;59:451-480.
32. Michetti P, Corthesy-Theulaz I, Davin C, et al. Immunisation of BALB/c mice against Helicobacter felis infection with H. pylon urease. Gastroenterol 1994;107:1002-1011.
33. Ferrero RL, Thiberge JM, Huerre M, et al. Recombinant antigens prepared from the urease subunits of Helicobacter spp: Evidence of protection in a mouse model of gastric infection. Infect Immun 1994;62:4981-4989.
34. Ferrero RL, Thiberge JM, Kansau I, et al. The GroES homolog of Helicobacter pylori confers rotective immunity against mucosal infection in mice. PNAS (USA) 1995;92:6499-6503.
35. Radcliff FJ, Chen M, Lee A. Protective immunisation against Helicobacter stimulates long term immunity. Vaccine 1996;14: 780-784.
36. Monath TP, Kleanthous H, Lee CK, et al. Development of recombinant Helicobacter pylori urease as an oral vaccine: Current status (abstract). Gut 1995;37(Suppl 1):A52.
37. Marchetti M, Arico B, Burroni D, et al. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655-1658.
38. Figura N, Guglielmetti P, Rossolim A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-226.
39. Dickinson BL, Clements JD. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 1995;63:1617-1623.
40. Douce G, Turcotte C, Cropley I, et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 1995;92: 1644-1623.
41. Michalek SM, Childers NK, Katz J, et al. Liposomes as oral adjuvants. In: Mestecky J, McGhee JR (eds) Current topics in microbiology and immunology. New strategies for oral immunisation. Berlin Heidelberg New York Tokyo: Springer, 1989;51-58.
42. Doidge C, Gust I, Lee A, et al. Therapeutic immunisation against Helicobacter infection. Lancet 1994;343:914-915.
43. Corthesy-Theulaz I, Vaney AC, Haas R, et al. H. pylori urease B subunit as a therapeutical vaccine against H. felis infection. Gastroenterol 1994;106:668A.
44. Corthesy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterol 1995;109: 115-121.
45. Anon. Acellular pertussis vaccines pass with flying colours. Biotechnol News 1995;15:2-3.
46. Handt LK, Fox JG, Stalis IH, et al. Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats. J Clin Microbiol 1995;33:2280-2289.
47. Eaton KA, Krakowka S. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterol 1992;103:1580-1586.
48. Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterol 1991;101:437-445.
49. Mitchell HM, Li YY, Hu PJ, et al. Epidemiology of Helicobacter pylori in Southern China - identification of early childhood as the critical period for acquisition. J Infect Dis 1992;166:149-153.
50. Yamada T, Ahnen D, Alpers DH, et al. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-69.